If you are living with Type 1 diabetes, you may be interested in a currently recruiting study from the world-renowned Joslin Diabetes Center.
The researchers are seeking to “identify and confirm substances that are associated with protection from complications of Type 1 diabetes” by studying people who have not developed severe eye and/or kidney disease after 30–49 years with Type 1. They aim to show that factors that are associated with protection from complications after 50 or more years with Type 1 diabetes may also be associated with protection from complications in those with higher HbA1c levels (an indicator of blood sugar control over the previous 2–3 months) but fewer years living with diabetes.
Eligible participants are those who have been living with Type 1 diabetes for 30–49 years, have an HbA1c level of at least 7.5%, and do not have proliferative eye disease or who do not have kidney disease.
For more information about the research, visit the Joslin Diabetes Center website. And for questions about the trial, contact Stephanie D’Eon at stephanie.d’eon@joslin.harvard.edu or (617) 309-4532.
This blog entry was written by Web Editor Diane Fennell.
